Open an account

McKesson

MCK · NYSE

$1,030.12+$19.69 (+1.95%)TodayMarket closed ·
Prev close $1,010.43

About MCK

McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.

Employees
43,000
Headquarters
Irving, Texas
Listed
Nov 10, 1994
Sector
Health Care
Industry
Health Care Providers & Services
Website
mckesson.com

MCK key statistics

Market cap
117.81B
Price-earnings ratio
27.08
Dividend yield
0.34%
Average volume
719.64K
Volume
475.31K
Open price
$1,021.14
High today
$1,030.27
Low today
$1,013.93
52 Week high
$1,014.99
52 Week low
$723.68

McKesson (MCK) at a glance

McKesson (MCK) last traded at $1,030.12, with a market cap of 117.81B, a price-to-earnings ratio of 27.08 and a dividend yield of 0.34%.

Today the stock has traded between $1,013.93 and $1,030.27. The current price is 1.6% above the day's low and 0.0% below its high.

Volume so far is 475.31K shares, below the average of 719.64K shares a day.

Over the past year McKesson has ranged from $723.68 to $1,014.99, and now sits 105% of the way up that range.

McKesson met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $9.93 per share against an estimate of $9.63.

The average analyst price target is $1,000.80, 2.8% below the current price, from 13 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

77%of 13 analyst ratings say Buy
  • Buy76.9%
  • Hold23.1%
  • Sell0.0%
Price target · 18 analystsAvg $1,000.80
Low
$853.45
Now
$1,030.12
High
$1,134.00

MCK earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 3.1% on average.

  1. Q4 FY24: reported $6.18 per share against an estimate of $6.41
  2. Q1 FY25: reported $7.88 per share against an estimate of $7.28
  3. Q2 FY25: reported $7.07 per share against an estimate of $6.95
  4. Q3 FY25: reported $8.03 per share against an estimate of $8.07
  5. Q4 FY25: reported $10.12 per share against an estimate of $9.92
  6. Q1 FY26: reported $11.69 per share against an estimate of $11.68
  7. Q1 FY27: reported $9.93 per share against an estimate of $9.63
  8. Q2 FY26: reported $9.93 per share against an estimate of $9.63

MCK news

  • Caroline Ryan

    Deal Dispatch: Uber Buys ezCater For $2.3B, Skydance Takes Over Warner Bros., True Food Kitchen Bankruptcy

  • Shivdeep Dhaliwal

    AMD, Constellation Energy, Marvell Technology, Option Care Health and FuelCell Energy: Why These 5 Stocks Are on Investors' Radars Today

  • Erica Kollmann

    Option Care Stock Trades Below McKesson's Deal Price — Here's the Spread

  • Vandana Singh

    McKesson Takes A Stake In Option Care — With An Option On The Rest

  • Press releaseBusiness Wire

    CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

  • Vandana Singh

    Cardinal Health, McKesson Double Down on CVS Deals Through 2032

  • Press releaseBusiness Wire

    McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health

  • Press releaseBusiness Wire

    McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date

Similar companies

Companies in the same industry as McKesson

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.